Axol Bioscience
Axol Bioscience specializes in human iPSC-derived cells and custom lab services for disease modeling and drug discovery, operating an ISO 9001:2015 accredited facility.
iPSC-Derived Cells
Axol Bioscience offers a wide range of human induced pluripotent stem cell (iPSC)-derived cells. These include neurons, cardiomyocytes, and sensory neurons. These iPSC-derived cells are used in various research and therapeutic applications, providing essential tools for scientists working in diverse fields such as neurology and cardiology.
Custom Lab Services
Axol Bioscience provides a suite of custom lab services. These services encompass reprogramming, gene editing, and cellular assays. By offering tailored lab solutions, Axol helps researchers and pharmaceutical companies achieve their specific research and development goals effectively and efficiently.
iPSC Library
Axol Bioscience maintains a commercial library of 70 iPSC lines from both patient and healthy donors. This diverse repository includes lines specific to various diseases such as Alzheimer’s Disease, Parkinson’s Disease, and ALS. These iPSC lines are crucial for disease modeling and developing bespoke therapeutic strategies.
iPSC Technology Applications
Axol Bioscience specializes in leveraging iPSC technology for disease modeling and drug discovery. Applications include neurotoxicity, sensorytoxicity, and cardiotoxicity testing. Additionally, Axol employs iPSC technology for drug discovery pursuits such as efficacy modeling and patient stratification.
ISO 9001:2015 Accredited Facility
Axol Bioscience operates an ISO 9001:2015 accredited production facility. This certification attests to its compliance with international standards for quality management systems, ensuring reliable and high-quality production processes for their iPSC-derived products and services.
